|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prados MD and Levin V: Biology and
treatment of malignant glioma. Semin Oncol. 27 (Suppl 6):S1–S10.
2000.
|
|
3
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang W, Yu H, Shen Y, Liu Y, Yang Z and
Sun T: MiR-146b-5p overexpression attenuates stemness and
radioresistance of glioma stem cells by targeting
HuR/lincRNA-p21/β-catenin pathway. Oncotarget. 7:41505–41526.
2016.PubMed/NCBI
|
|
6
|
Feng S, Yao J, Chen Y, Geng P, Zhang H, Ma
X, Zhao J and Yu X: Expression and functional role of
reprogramming-related long noncoding RNA (lincRNA-ROR) in glioma. J
Mol Neurosci. 56:623–630. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wutz A: Gene silencing in X-chromosome
inactivation: Advances in understanding facultative heterochromatin
formation. Nat Rev Genet. 12:542–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Yuan J, Li L, Yang Y, Xu X and
Wang Y: Long non-coding RNA XIST exerts oncogenic functions in
human glioma by targeting miR-137. Am J Transl Res. 9:1845–1855.
2017.PubMed/NCBI
|
|
9
|
Wei W, Liu Y, Lu Y, Yang B and Tang L:
LncRNA XIST promotes pancreatic cancer proliferation through
miR-133a/EGFR. J Cell Biochem. 118:3349–3358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li S, Qin X, Li Y, Zhang X, Niu R, Zhang
H, Cui A, An W and Wang X: MiR-133a suppresses the migration and
invasion of esophageal cancer cells by targeting the EMT regulator
SOX4. Am J Transl Res. 7:1390–1403. 2015.PubMed/NCBI
|
|
11
|
Jafarnejad SM, Ardekani GS, Ghaffari M and
Li G: Pleiotropic function of SRY-related HMG box transcription
factor 4 in regulation of tumorigenesis. Cell Mol Life Sci.
70:2677–2696. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schilham MW, Oosterwegel MA, Moerer P, Ya
J, de Boer PA, van de Wetering M, Verbeek S, Lamers WH, Kruisbeek
AM, Cumano A and Clevers H: Defects in cardiac outflow tract
formation and pro-B-lymphocyte expansion in mice lacking Sox-4.
Nature. 380:711–714. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ya J, Schilham MW, de Boer PA, Moorman AF,
Clevers H and Lamers WH: Sox4-deficiency syndrome in mice is an
animal model for common trunk. Circ Res. 83:986–994. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheung M, Abu-Elmagd M, Clevers H and
Scotting PJ: Roles of Sox4 in central nervous system development.
Brain Res Mol Brain Res. 79:180–191. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen J, Ju HL, Yuan XY, Wang TJ and Lai
BQ: SOX4 is a potential prognostic factor in human cancers: A
systematic review and meta-analysis. Clin Transl Oncol. 18:65–72.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi S, Cao X, Gu M, You B, Shan Y and You
Y: Upregulated expression of SOX4 is associated with tumor growth
and metastasis in nasopharyngeal carcinoma. Dis Markers.
2015:6581412015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Foronda M, Martínez P, Schoeftner S,
Gómez-López G, Schneider R, Flores JM, Pisano DG and Blasco MA:
Sox4 links tumor suppression to accelerated aging in mice by
modulating stem cell activation. Cell Rep. 8:487–500. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Khachane AN and Harrison PM: Mining
mammalian transcript data for functional long non-coding RNAs. PLoS
One. 5:e103162010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Cao X, Zhang L, Zhang X, Sheng H
and Tao K: UCA1 overexpression predicts clinical outcome of
patients with ovarian cancer receiving adjuvant chemotherapy.
Cancer Chemother Pharmacol. 77:629–634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song H, He P, Shao T, Li Y, Li J and Zhang
Y: Long non-coding RNA XIST functions as an oncogene in human
colorectal cancer by targeting miR-132-3p. J BUON. 22:696–703.
2017.PubMed/NCBI
|
|
22
|
Tang Y, He R, An J, Deng P, Huang L and
Yang W: lncRNA XIST interacts with miR-140 to modulate lung cancer
growth by targeting iASPP. Oncol Rep. 38:941–948. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dai W, Xu X, Li S, Ma J, Shi Q, Guo S, Liu
L, Guo W, Xu P, He Y, et al: SOX4 promotes proliferative signals by
regulating glycolysis through AKT activation in melanoma cells. J
Invest Dermatol. 137:2407–2416. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vervoort SJ, van Boxtel R and Coffer PJ:
The role of SRY-related HMG box transcription factor 4 (SOX4) in
tumorigenesis and metastasis: Friend or foe? Oncogene.
32:3397–3409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vervoort SJ, Lourenco AR, van Boxtel R and
Coffer PJ: SOX4 mediates TGF-β-induced expression of mesenchymal
markers during mammary cell epithelial to mesenchymal transition.
PLoS One. 8:e532382013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Manalo DJ, Rowan A, Lavoie T, Natarajan L,
Kelly BD, Ye SQ, Garcia JG and Semenza GL: Transcriptional
regulation of vascular endothelial cell responses to hypoxia by
HIF-1. Blood. 105:659–669. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Banno T, Gazel A and Blumenberg M: Effects
of tumor necrosis factor-alpha (TNF alpha) in epidermal
keratinocytes revealed using global transcriptional profiling. J
Biol Chem. 279:32633–32642. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mishra P and Chan DC: Metabolic regulation
of mitochondrial dynamics. J Cell Boil. 212:379–387. 2016.
View Article : Google Scholar
|
|
29
|
Mei Q, Li X, Guo M, Fu X and Han W: The
miRNA network: Micro-regulator of cell signalling in cancer. Expert
Rev Anticancer Ther. 14:1515–1527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nohata N, Hanazawa T, Kikkawa N, Mutallip
M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H,
Nakagawa M, et al: Caveolin-1 mediates tumor cell migration and
invasion and its regulation by miR-133a in head and neck squamous
cell carcinoma. Int J Oncol. 38:209–217. 2011.PubMed/NCBI
|
|
32
|
Xu M and Wang YZ: miR133a suppresses cell
proliferation, migration and invasion in human lung cancer by
targeting MMP14. Oncol Rep. 30:1398–1404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen G, Fang T, Huang Z, Qi Y, Du S, Di T,
Lei Z, Zhang X and Yan W: MicroRNA-133a inhibits osteosarcoma cells
proliferation and invasion via targeting IGF-1R. Cell Physiol
Biochem. 38:598–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sakr M, Takino T, Sabit H, Nakada M, Li Z
and Sato H: miR-150-5p and miR-133a suppress glioma cell
proliferation and migration through targeting membrane-type-1
matrix metalloproteinase. Gene. 587:155–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ye ZQ, Wang T and Song W: Long noncoding
RNAs in prostate cancer. Zhonghua Nan Ke Xue. 20:963–968. 2014.(In
Chinese). PubMed/NCBI
|
|
36
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL,
Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding
RNA XIST regulates gastric cancer progression by acting as a
molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin
Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sarver AL and Subramanian S: Competing
endogenous RNA database. Bioinformation. 8:731–733. 2012.
View Article : Google Scholar : PubMed/NCBI
|
